Fabian earned a B.S. in molecular biology from Heidelberg University and a Master of Science in systems biology from ETH Zurich. During his pre-doctoral studies, he was granted scholarships from the German Academic Scholarship Foundation, and later, the Boehringer Ingelheim Fond supported his doctoral research under the guidance of Prof. Dr. Winfried Denk at the Max Planck Institute of Neurobiology in Munich. Previously, Fabian worked as a postdoctoral researcher in Dr. Kevin Briggman laboratory at the Max Planck Institute for Neurobiology of Behavior in Bonn.

Joergen contributes over 15 years of experience with machine learning and the analysis of massive microscopy image data sets. He was trained in computational biology and bioinformatics at ETH Zurich (MSc), and then received a prestigious Boehringer Ingelheim Fellowship for his doctoral studies with Prof. Dr. Winfried Denk at the Max Planck Institute of Neurobiology which he finished with highest honors. He was a postdoctoral researcher at the Massachusetts Institute of Technology, collaborates closely with laboratories at the New York University and Google AI, and leads a research group at the Max Planck Institute for Biological Intelligence near Munich.

Lucas studied Biosciences and obtained his PhD in developmental biology at Heidelberg University. Starting with his bachelor thesis he focused more and more on microscopy and image analysis. During his doctoral work in the lab of Prof. Dr. Steffen Lemke he worked on 3-dimensional tissue folding in Drosophila and developed his own plugins for ImageJ. Before joining ariadne.ai as COO he worked 2 ½ years at the Advanced Light Microscopy facility of the European Molecular biology laboratory (EMBL) where he specialized in automated as well as feedback microscopy and quality control.

Adrian founded ariadne.ai during his doctoral work with Prof. Dr. Rainer Friedrich at the Friedrich Miescher Institute for Biomedical Research (Novartis) in Basel, Switzerland. In 2016, he was awarded with the Ruth Chiquet-Ehrismann Originality Prize. Adrian holds a Master of Science in theoretical physics and neuroinformatics from ETH Zurich and is a C.V. Starr Fellow at Princeton University studying the neuronal basis of working memory in collaboration with Prof. Dr. Sebastian Seung and Prof. Dr. David Tank. In 2022 he was awarded with an ERC Starting Grant and he is currently leading the Structural Neurobiology research group at the Paul Scherrer Institute in Switzerland.

Emanuel is a passionate contract lawyer. At ariadne.ai, he safeguards that all the brilliant ideas do not struggle at the stage of legal and administrative implementation. After graduating from the Universities of Zurich and Oslo, he passed the Zurich bar exam and currently serves as senior law clerk and judge at the District Court of Zurich dealing with commercial matters.

Peter started his career in the computer and medtech industry, where he worked, among others, for General Electric Company. After several years in the Customer Service of Philips, Peter became General Director of Philips Medical Systems of Austria and Switzerland in 2003. From 2005, Peter served as CEO and President of the Board of Directors of Philips Switzerland. Peter holds a degree in electrical engineering and information technology and an executive MBA from the University of St. Gallen, Switzerland.

Sandro joined Zurich in 1994 from Winterthur Reinsurance Corp. and launched his career in the strategic business unit formerly known as Life International. Between 2001 and 2006, he built up the Zurich Employee Benefit Network (ZEBN) as part of Global Corporate’s International Program Business. In 2006, he relocated to Chicago as Senior Vice President for Global Corporate North America to introduce the Customer Relationship Management model. In August 2010, Sandro became Head of Life & Pensions (CLP) and serves as Head of Life since July 2018.

Prof. Roska is a renowned expert in neurobiology and a pioneer in retinal research. He is director of the Institute of Molecular and Clinical Ophthalmology, a joint-venture between Novartis and the University Hospital Basel. He is a Professor at the Faculty of Medicine of the University of Basel since 2014 and earned his MD at the Semmelweis University of Medicine in Budapest. After his PhD at the University of California, Berkeley, he became a Harvard Junior Fellow at Harvard University. In 2005 he started his research group at the Friedrich Miescher Institute for Biomedical Research. Prof. Roska has received numerous prestigious honours and awards, including the Alcon Award, the Alfred Vogt Award, and the Cogan Award.